Valuation check: MNKKQ's profit margin is -52.82%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for MNKKQ is -52.82% as of June 2026. That compares with 90.62% in the prior-year period — down 158.3% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Mallinckrodt Plc's historical trend and sector peers before judging valuation or financial health.
Over the past year, MNKKQ's profit margin moved from 90.62% to -52.82% — a 158.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mallinckrodt Plc's valuation or profitability profile.
Against Healthcare companies, MNKKQ currently prints -52.82% for profit margin, while the sector average sits near 13.89%. That is roughly 480.2% below the sector mean. Large gaps often invite a closer look at Mallinckrodt Plc's growth, margins, and balance sheet.
Profit Margin shows how effectively Mallinckrodt Plc converts resources into returns. At -52.82%, MNKKQ may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 90.62% in the prior-year period — down 158.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MNKKQ's profit margin (-52.82%), review year-over-year change from 90.62%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.